Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.722 USD | -12.70% |
|
-19.77% | +115.61% |
24/05 | Monopar Therapeutics Names Karthik Radhakrishnan as CFO | MT |
24/05 | Monopar Therapeutics Inc. Announces CFO Changes | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+115.61% | 1.45Cr | |
+35.25% | 5.11TCr | |
-8.18% | 3.88TCr | |
+35.11% | 3.86TCr | |
-8.98% | 2.73TCr | |
+11.54% | 2.63TCr | |
-19.18% | 1.95TCr | |
+40.70% | 1.36TCr | |
+30.46% | 1.25TCr | |
-4.13% | 1.17TCr |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Monopar Therapeutics Inc. Announces Termination of Employment of Kirsten Anderson, Senior Vice President of Clinical Development